How Electrical Storms Recur Over Time in Patients With Implantable Cardioverter Defibrillators - Subanalysis of the Nippon Storm Study -

被引:0
|
作者
Yasuoka, Ryobun [1 ]
Maruyama, Masahiro [1 ]
Nakazawa, Gaku [1 ]
Noda, Takashi [2 ]
Nitta, Takashi [3 ]
Aizawa, Yoshifusa [4 ]
Ohe, Tohru [5 ]
Kurita, Takashi [1 ]
机构
[1] Kindai Univ Hosp, Div Cardiol, 377-2 Ohno Higashi, Osaka 5898511, Japan
[2] Tohoku Univ, Grad Sch Med, Div Cardiol, Sendai, Japan
[3] Hanyu Gen Hosp, Saitama, Japan
[4] Tachikawa Med Ctr, Dept Res & Dev, Niigata, Japan
[5] Okayama City Hosp, Okayama, Japan
关键词
Electrical storm; Implantable cardioverter defibrillator; Primary prevention; Recurrent event analysis; CARDIAC-RESYNCHRONIZATION THERAPY; VENTRICULAR-TACHYCARDIA; CATHETER ABLATION; MANAGEMENT; DEATH; TERM; PHARMACOTHERAPY; PREVENTION; PREDICTORS; GUIDELINE;
D O I
10.1253/circj.CJ-24-0390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Electrical storms (E-storms), defined as multiple fatal ventricular arrhythmias over a short period, negatively affect the prognosis of patients receiving an implantable cardioverter defibrillator or cardiac resynchronization therapy with a defibrillator (ICD/ CRT-D). However, the prognostic impact of recurrent E-storms has not been well elucidated. Methods and Results: We analyzed the association between E-storm recurrences and mortality using data from 1,274 participants in the Nippon Storm Study, a prospective observational study conducted at 48 ICD/CRT-D centers in Japan. Differences in E-storm recurrences by patient characteristics were evaluated using the mean cumulative function (MCF), which is the cumulative number of E-storm episodes per patient as a function of time. Patients with multiple E-storms had a 3.39-fold higher mortality risk than those without E-storms (95% confidence interval 1.82-6.28; P<0.01). However, there was no significant difference in mortality risk between patients with a single E-storm and those without E-storms. The MCF curve exhibited a slower ascent in patients who received primary prevention ICD/CRT-D than in those who received secondary prevention ICD/CRT-D. However, when analyzing only patients with E-storms, the MCF curves demonstrated comparable trajectories in both groups. Conclusions: E-storm recurrences may have a negative impact on prognosis. Once patients with primary prevention experience an E-storm episode, they face a similar risk of subsequent recurrent E-storms as patients with secondary prevention.
引用
收藏
页码:214 / 223
页数:10
相关论文
共 50 条
  • [21] Electrical Storm in patients with an Implantable Cardioverter-Defibrillator
    Leibundgut, G.
    Osswald, S.
    Sticherling, C.
    Kuehne, M.
    Schaer, B.
    EUROPEAN HEART JOURNAL, 2009, 30 : 556 - 556
  • [23] Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time
    von Gunten, Simon
    Schaer, Beat A.
    Yap, Sing-Chien
    Szili-Torok, Tamas
    Kuhne, Michael
    Sticherling, Christian
    Osswald, Stefan
    Theuns, Dominic A. M. J.
    EUROPACE, 2016, 18 (05): : 710 - 717
  • [24] Longevity of implantable cardioverter defibrillators: a comparison among manufactures and over time
    Schaer, B. A.
    Von Gunten, S.
    Kuehne, M.
    Sticherling, C.
    Osswald, S.
    Szili-Torok, T.
    Yap, S.
    Theuns, D. A. M. J.
    EUROPEAN HEART JOURNAL, 2015, 36 : 47 - 47
  • [25] Neuromuscular electrical stimulation of the thighs in cardiac patients with implantable cardioverter defibrillators
    Cenik, Fadime
    Schoberwalter, Dieter
    Keilani, Mohammad
    Maehr, Bruno
    Wolzt, Michael
    Marhold, Maximilian
    Crevenna, Richard
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 (21-22) : 802 - 808
  • [26] Neuromuscular electrical stimulation of the thighs in cardiac patients with implantable cardioverter defibrillators
    Fadime Cenik
    Dieter Schoberwalter
    Mohammad Keilani
    Bruno Maehr
    Michael Wolzt
    Maximilian Marhold
    Richard Crevenna
    Wiener klinische Wochenschrift, 2016, 128 : 802 - 808
  • [27] ARRHYTHMIC STORM IN PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS BECAUSE OF ISCHEMIC VENTRICULAR DYSFUNCTION
    Garcia Bellon, A. M.
    Ramirez Marrero, M. A.
    Perez Villardon, B.
    Gonzalez Gonzalez, A. M.
    Jimenez Rubio, C.
    Cano Nieto, J. A.
    Delgado Prieto, J. L.
    Perez Ruiz, J. M.
    De Mora Martin, M.
    INTENSIVE CARE MEDICINE, 2011, 37 : S55 - S55
  • [28] Electrical storm in patients with implantable cardioverter defibrillators: management with selective vs non selective b-adrenergic blockade
    Chatzidou, S.
    Vassilopoulos, G.
    Voyatzis, S.
    Skoura, A.
    Rokas, S.
    Rokas, S.
    EUROPEAN HEART JOURNAL, 2005, 26 : 427 - 427
  • [29] Reimplantation surgery in patients with implantable cardioverter defibrillators: A qualitative study
    Jakub, Karen E.
    Sandelowski, Margarete
    HEART & LUNG, 2016, 45 (01): : 48 - 55
  • [30] Ranolazine in Patients With Implantable Cardioverter-Defibrillators Ready for Prime Time?
    Albert, Christine M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (06) : 646 - 649